Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFP Peptide-Pulsed DC Vaccine in HCC
NCT00022334Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jan 2001
- Primary completion
- Dec 2004
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-fetoprotein peptide-pulsed autologous dendritic cells in hepatocellular carcinoma (HCC), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jan 2001; status: completed.
02
Drugs
alpha-fetoprotein peptide-pulsed autologous dendritic cells
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00022334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022334.